Quantcast

Latest Analgesics Stories

2014-06-12 23:02:38

The Firm is evaluating Tylenol lawsuits on behalf of individuals who allegedly suffered severe liver damage due to acetaminophen in over-the-counter Tylenol products. New York, New York (PRWEB) June 12, 2014 Tylenol lawsuits http://www.tylenollawsuitclaims.com/) filed on behalf of individuals who allegedly suffered severe liver damage due to the acetaminophen in over-the-counter Tylenol products continue to move forward in the U.S. District Court, Eastern District of Pennsylvania,...

2014-06-10 23:00:59

The Firm is investigating Tylenol lawsuits on behalf of patients who allegedly suffered acetaminophen-induced liver damage due to their use of Tylenol-brand over-the-counter medications. New York, New York (PRWEB) June 10, 2014 As Tylenol lawsuits (http://www.tylenollawsuitclaims.com/) continue to mount in U.S. courts, Bernstein Liebhard LLP notes that the U.S. Food & Drug Administration (FDA) has issued yet another caution regarding the potential for acetaminophen, the active...

2014-06-09 08:29:51

When You Honor Someone Who Has Made You Strong, TYLENOL® will Make a Donation to DoSomething.Org FORT WASHINGTON, Pa., June 9, 2014 /PRNewswire-USNewswire/ -- McNeil Consumer Healthcare Division of McNEIL-PPC, Inc., the makers of Extra Strength TYLENOL(®), today announced the launch of STORIES OF STRENGTH, a program that encourages people to honor someone who has been a source of strength in their lives. Each story shared will trigger a $1 donation (with a minimum donation of...

2014-06-03 16:24:56

During National Safety Month, NSC urges Americans to take precautions when taking prescription painkillers ITASCA, Ill., June 3, 2014 /PRNewswire-USNewswire/ -- Drug overdoses are now the leading cause of unintentional injury-related death for Americans ages 25 to 64. Opioid prescription painkillers - legally obtainable drugs that are sitting in many medicine cabinets - account for most of these fatal drug overdoses. http://photos.prnewswire.com/prnvar/20130530/MM23334-b During National...

2014-05-28 08:32:01

Controlled Substance Analgesic Combination Product Uses Depomed's Proprietary Acuform® Technology NEWARK, Calif., May 28, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ:DEPO) announced today that the U. S. Food and Drug Administration (FDA) has accepted for filing a New Drug Application (NDA) from Mallinckrodt (NYSE: MNK) for MNK-155. MNK-155 is an investigational extended-release oral formulation of hydrocodone and acetaminophen that has been studied for the management of moderate to...

2014-05-26 23:02:58

The Firm is actively investigating Tylenol liver damage lawsuits on behalf of individuals allegedly injured by acetaminophen, the over-the-counter pain reliever’s active ingredient. New York, NY (PRWEB) May 26, 2014 A number of additional Tylenol lawsuits (http://www.tylenollawsuitclaims.com/ ) alleging liver damage have been filed in a federal litigation currently underway in the U.S. District Court, District of Eastern Pennsylvania over the past month, Bernstein Liebhard LLP reports....

2014-05-13 16:28:49

- Launched promotional efforts to support Omeclamox®-Pak NASHVILLE, Tenn., May 13, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company focused on hospital acute care and gastroenterology, today announced first quarter 2014 financial results. During the quarter the Company returned to profitability, launched two new products, and continued to maintain positive cash flow from operations....

2014-05-13 08:31:28

SAN DIEGO, May 13, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento) a late-stage clinical oncology company developing new treatments for cancer and its associated pain, today announced that the U.S. Office of Orphan Products Development at the Food and Drug Administration (FDA) has approved the transfer of sponsorship of the Orphan Drug Designation for intrathecal resiniferatoxin (RTX) in the treatment of intractable pain in end-stage disease from the...

2014-05-12 08:31:24

Product is being developed to treat pain in dogs with osteoarthritis KANSAS CITY, Kan., May 12, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative biopharmaceutical products for cats, dogs and other companion animals, today announced the initiation of the pivotal field effectiveness study for AT-001 (grapiprant), the company's innovative drug for treating pain in dogs...

2014-05-07 08:31:48

-Vaprisol marks new product for hospital sales force NASHVILLE, Tenn., May 7, 2014 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) today announced the launch of its active promotional campaign to support its new Vaprisol(®) product. Cumberland will promote Vaprisol across the United States through its hospital sales force. A National Sales Meeting was convened this week to officially launch active promotion and other efforts to support the brand. Cumberland acquired...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related